(WSVN) - Pfizer has recalled large quantities of its blood pressure and heart medication Accupril after testing revealed it might contain an organic compound that has been linked to a higher risk of contracting cancer.

The pharmaceutical corporation announced the recall of five lots of the medication on Friday.

The Accupril tablets included in the recall come in 90 count bottles with strengths of 10, 20 and 40 milligrams.

According to Pfizer’s notice, Accupril is used for “the treatment of hypertension, to lower blood pressure” and “the management of heart failure as adjunctive therapy.”

Pfizer officials said they have recalled the medication because the levels of nitrosamine are above the Food and Drug Administration’s accepted daily intake.

Low levels of nitrosamine are common in water and some foods, but Pfizer’s notice states, “These impurities may increase the risk of cancer if people are exposed to them above acceptable levels over long periods of time.”

The announcement comes one month after Pfizer issued a similar recall of its hypertension drug Accuretic and its two generic versions.

Consumers who have bought the recalled bottles are advised to consult with their health care provider. They are also advised to contact Sedgwick at 888-345-481, Monday thru Friday from 8 a.m. to 5 p.m., for details about how to return the tablets for a refund.

Copyright 2022 Sunbeam Television Corp. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Join our Newsletter for the latest news right to your inbox